Glen Harbor Capital Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Glen Harbor Capital Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-253	Closed	-$17K	–	1310
2018 Q1	$17K	Sell	253 -767	-75%	-$54.3K	﹤0.01%	1273
2017 Q4	$74K	Sell	1,020 -733	-42%	-$60.6K	﹤0.01%	1190
2017 Q3	$161K	Sell	1,753 -215	-11%	-$16.5K	﹤0.01%	985
2017 Q2	$130K	Sell	1,968 -658	-25%	-$81.5K	﹤0.01%	1002
2017 Q1	$569K	Hold	2,626	–	–	0.01%	527
2016 Q4	$243K	Buy	+2,626	New	+$296K	0.01%	666

Other funds holding LUMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Glen Harbor Capital Management's LUMO Position: Q2 2018 in Review

Glen Harbor Capital Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2018, closing a stake of 253 shares — an estimated $17K sold.

Glen Harbor Capital Management first reported a position in LUMO in Q4 2016 and held it in 6 quarters. The position peaked at $569K in Q1 2017. 106 funds tracked by Wall St. Rank hold LUMO as of Q2 2018.

Glen Harbor Capital Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
Glen Harbor Capital Management sold 253 Lumos Pharma, Inc. Common Stock shares in Q2 2018, an estimated $17K.
Glen Harbor Capital Management first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2016 and held it in 6 quarters.
Glen Harbor Capital Management's Lumos Pharma, Inc. Common Stock position peaked at $569K in Q1 2017.
106 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2018.

Based on Glen Harbor Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.